The Cell Therapy Center, represented by Dr. Nidaa Ababneh, participated in the Genomics of Rare Disease 2025 conference, which was held in Cambridge / United Kingdom in the period (9-11) of this month.
Where Dr. Ababneh participated in presenting a Poster presentation entitled
Investigating Retinitis Pigmentosa Mechanisms Using iPSC-Derived RPE Cells With a Novel MERTK Variant”